OpenVSafe by OpenVAERS
Search V-safe

3BG-23401-65126

4 vaccinations 10 coded responses 29 check-ins 10 free-text entries 5 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
038 / NH
Registered
2021-05-29
Relationship
Self
Race
Multiracial
Ethnicity
Not Hispanic or Latino
Registered dependents
ZE5-20187-68032 Child or adolescent in my care · Female · 2021-06-26

Timeline

  1. 2021-03-22
    Dose 1 — Moderna
  2. 2021-04-19
    Dose 2 — Moderna
  3. 2021-05-29
    Registered in v-safe
  4. 2021-05-29
    Health check-in — day 35, dose 2
    Feeling: Fair
    Adult check-in
  5. 2021-05-31
    Health check-in — day 42, dose 2
    Feeling: Fair
    Adult check-in
  6. 2021-07-19
    Survey response — 3 months, dose 2
    MedDRA: Fatigue, Headache, Pain — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Extra pain, headaches and fatigue.
    MedDRA releases: 2024-11 · check-in free text available
  7. 2021-07-19
    Report sent to call center — 3 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  8. 2021-07-27
  9. 2021-07-30
  10. 2021-10-18
    Survey response — 6 months, dose 2
    MedDRA: Hepatic enzyme increased, Neuropathy peripheral, Surgery, Thoracic outlet syndrome — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Neuropathy associated with thoracic outlet syndrome post surgery. Increase in liver enzymes
    MedDRA releases: 2024-11 · check-in free text available
  11. 2021-10-18
    Report sent to call center — 6 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  12. 2021-10-20
  13. 2021-10-23
  14. 2021-12-15
    Dose 3 — Pfizer-BioNTech
  15. 2021-12-18
    Survey response — days 1–6 daily, dose 3
    MedDRA: Dizziness — Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Dizziness, moderate
    MedDRA releases: 2024-11 · check-in free text available
  16. 2021-12-19
    Survey response — days 1–6 daily, dose 3
    MedDRA: Dizziness — Feeling: Fair · Muscle or body aches
    Free text: Dizziness, mild
    MedDRA releases: 2024-11 · check-in free text available
  17. 2021-12-20
    Survey response — days 1–6 daily, dose 3
    MedDRA: Dizziness — Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Dizziness, mild
    MedDRA releases: 2024-11 · check-in free text available
  18. 2021-12-21
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  19. 2021-12-22
    Health check-in — day 7, dose 3
    Feeling: Fair · Headache, Muscle or body aches
    Adult check-in
  20. 2021-12-29
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  21. 2022-01-07
    Health check-in — day 21, dose 3
    Feeling: Fair
    Adult check-in
  22. 2022-01-12
    Survey response — day 28, dose 3
    MedDRA: Cough, Fatigue, Insomnia, Oropharyngeal pain, Respiratory tract congestion — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Continuing cough, sore throat and congestion with extreme fatigue and insomnia
    MedDRA releases: 2024-11 · check-in free text available
  23. 2022-01-12
    Report sent to call center — day 28, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  24. 2022-01-13
  25. 2022-01-18
  26. 2022-01-19
    Health check-in — day 35, dose 3
    Feeling: Fair
    Adult check-in
  27. 2022-01-28
    Survey response — day 42, dose 3
    MedDRA: Diarrhoea — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Constant Diahhrea
    MedDRA releases: 2024-11 · check-in free text available
  28. 2022-01-28
    Report sent to call center — day 42, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  29. 2022-02-01
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  30. 2022-02-01
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  31. 2022-02-01
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  32. 2022-02-01
    Call successful
    Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
  33. 2022-03-16
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  34. 2022-06-17
    Health check-in — 6 months, dose 3
    Feeling: Fair
    Adult check-in
  35. 2022-10-14
    Dose 4 — Pfizer-BioNTech
  36. 2022-10-15
    Survey response — days 1–6 daily, dose 4
    MedDRA: Dizziness — Feeling: Poor · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Free text: Dizzy/lightheadedness
    MedDRA releases: 2024-11 · check-in free text available
  37. 2022-10-16
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Site: Pain, Swelling, Itching · Headache, Joint pains, Muscle or body aches
    Adult check-in
  38. 2022-10-17
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Site: Pain · Joint pains
    Adult check-in
  39. 2022-10-18
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  40. 2022-10-19
    Survey response — days 1–6 daily, dose 4
    MedDRA: Oropharyngeal pain — Feeling: Fair · Site: Pain · Headache, Muscle or body aches
    Free text: Sore throat
    MedDRA releases: 2024-11 · check-in free text available
  41. 2022-10-21
    Health check-in — day 7, dose 4
    Feeling: Fair · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain
    Adult check-in
  42. 2022-10-28
    Survey response — day 14, dose 4
    MedDRA: Arthralgia, Diaphragmalgia, Menstrual disorder, Migraine, Myalgia, Pain, Pelvic pain — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Pain throughout my body including joints, muscles, diaphragm, and pelvic pain. Abnormal menstrual bleeding and migration headaches.
    MedDRA releases: 2024-11 · check-in free text available
  43. 2022-10-28
    Report sent to call center — day 14, dose 4
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  44. 2022-10-31
    Call successful
    Participant prefers to complete VAERS report online
  45. 2022-11-04
    Health check-in — day 21, dose 4
    Feeling: Fair
    Adult check-in
  46. 2022-11-13
    Health check-in — day 28, dose 4
    Feeling: Fair
    Adult check-in
  47. 2022-11-18
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  48. 2022-11-25
    Health check-in — day 42, dose 4
    Feeling: Fair
    Adult check-in
  49. 2023-01-13
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  50. 2023-04-14
    Health check-in — 6 months, dose 4
    Feeling: Fair
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-03-22Moderna
22021-04-19Moderna
32021-12-15Pfizer-BioNTech No
42022-10-14Pfizer-BioNTech No

Call center

5 call center cases

5 successful

See the call center timeline

Free text

Release 9 — 3 months, dose 2

2021-07-19

Symptoms: Extra pain, headaches and fatigue.

Release 10 — 6 months, dose 2

2021-10-18

Symptoms: Neuropathy associated with thoracic outlet syndrome post surgery. Increase in liver enzymes

Release 10 — days 1–6 daily, dose 3

2021-12-18

Systemic reaction (other): Dizziness, moderate

2021-12-19

Systemic reaction (other): Dizziness, mild

2021-12-20

Systemic reaction (other): Dizziness, mild

Release 10 — day 28, dose 3

2022-01-12

Symptoms: Continuing cough, sore throat and congestion with extreme fatigue and insomnia

Release 11 — day 42, dose 3

2022-01-28

Symptoms: Constant Diahhrea

Release 12 — days 1–6 daily, dose 4

2022-10-15

Systemic reaction (other): Dizzy/lightheadedness

2022-10-19

Systemic reaction (other): Sore throat

Release 12 — day 14, dose 4

2022-10-28

Symptoms: Pain throughout my body including joints, muscles, diaphragm, and pelvic pain. Abnormal menstrual bleeding and migration headaches.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDArthralgia · · ✓
SDCough · · ✓
SDDiaphragmalgia · · ✓
SDDiarrhoea · · ✓
SDFatigue · · ✓
SDHeadache · · ✓
SDHepatic enzyme increased · · ✓
SDInsomnia · · ✓
SDMenstrual disorder · · ✓
SDMigraine · · ✓
SDMyalgia · · ✓
SDNeuropathy peripheral · · ✓
SDOropharyngeal pain · · ✓
SDPain · · ✓
SDPelvic pain · · ✓
SDRespiratory tract congestion · · ✓
SDSurgery · · ✓
SDThoracic outlet syndrome · · ✓
SRODizziness · · ✓
SROOropharyngeal pain · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release